Literature DB >> 31787410

Large-scale influenza vaccination promotion on a mobile app platform: A randomized controlled trial.

Wei-Nchih Lee1, David Stück2, Kevin Konty3, Caitlin Rivers4, Courtney R Brown5, Susan M Zbikowski6, Luca Foschini7.   

Abstract

While health-care providers have used incentives in an attempt to motivate patients to obtain vaccinations, their effect on vaccination rates has not been systematically evaluated on a large scale. In this study, we examined whether mobile applications may improve population vaccination rates through enhanced communication and incentives education. Our study is the first randomized controlled trial assessing the effect of large-scale messaging combined with individualized incentives on influenza-vaccination rates. In this trial, we delivered messages regarding influenza vaccinations to 50,286 adults, aged 18 through 65, then compared the subsequent vaccination rate, the effectiveness of the message content and the timing. Multiple rounds of messaging occurred over a seven-week period during the 2016 flu season, after which vaccination rates were observed for one week. Participants were randomly assigned to one of three messaging approaches: conspicuous (highlighting the amount of rewards to be received for obtaining a flu shot); generic (promoting vaccinations with no mention of rewards); or no-message. Evidence of vaccination obtainment was indicated by medical and pharmacy claims, augmented by patients self-reporting through the mobile wellness app during the study period. Of the people assigned to receive messaging, 23.2% obtained influenza vaccination, compared to 22.0% of people who obtained vaccination in the no-messaging control arm. This difference was statistically significant (p < 0.01). The research revealed that messaging effectiveness decreased after each successive batch sent, suggesting that most participants responsive to messaging would become activated immediately after receiving one alert. Interestingly, in this large-scale study, there were no significant differences between conspicuous incentives and generic messaging, suggesting an important area for future research. Trial Registration: clinicaltrials.gov identifier: NCT02908893.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31787410     DOI: 10.1016/j.vaccine.2019.11.053

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Influence of Digital Intervention Messaging on Influenza Vaccination Rates Among Adults With Cardiovascular Disease in the United States: Decentralized Randomized Controlled Trial.

Authors:  Nell J Marshall; Jennifer L Lee; Jessica Schroeder; Wei-Nchih Lee; Jermyn See; Mohammad Madjid; Mrudula R Munagala; John D Piette; Litjen Tan; Orly Vardeny; Michael Greenberg; Jan Liska; Monica Mercer; Sandrine Samson
Journal:  J Med Internet Res       Date:  2022-10-07       Impact factor: 7.076

Review 2.  Increasing Seasonal Influenza Vaccination among University Students: A Systematic Review of Programs Using a Social Marketing Perspective.

Authors:  Daisy Lee; Sharyn Rundle-Thiele; Tai Ming Wut; Gabriel Li
Journal:  Int J Environ Res Public Health       Date:  2022-06-10       Impact factor: 4.614

3.  Knowledge and practice toward seasonal influenza vaccine and its barriers at the community level in Riyadh, Saudi Arabia.

Authors:  Alaa A Aljamili
Journal:  J Family Med Prim Care       Date:  2020-03-26

4.  A rapid global review of strategies to improve influenza vaccination uptake in Australia.

Authors:  Hassen Mohammed; Mark McMillan; Prabha H Andraweera; Salenna R Elliott; Helen S Marshall
Journal:  Hum Vaccin Immunother       Date:  2021-10-08       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.